ImageneBio, Inc.
IMA· Nasdaq
Released Aug 11, 2022, before the open
10-Q filed Aug 11, 2022, 42 days after period end · 0000950170-22-016600
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $382.00K | $3.55M | $3.07M |
| Net Income | -$20.49M | -$12.68M | -$5.04M |
| EPS Diluted | -$0.57 | -$0.35 | -$1.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR